• Amyotrophic lateral sclerosis
• Cachexia
• Cancer
• Cerebral Palsy
• Chronic neuropathic pain associated with degenerative spinal disorders
• Chronic pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention
• Chronic pancreatitis (subject to approval by the legislature’s Regulations Review Committee)
• Complex regional pain syndrome
• Crohn’s disease
• Cystic Fibrosis
• Ehlers-Danlos Syndrome
• Epilepsy
• Glaucoma
• Hydrocephalus with intractable headache
• HIV or AIDS
• Interstitial cystitis
• Intractable headache syndromes
• Intractable neuropathic pain that is unresponsive to standard medical treatments
• Intractable spasticity
• Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity
• Medial arcuate ligament syndrome, or MALS syndrome
• Multiple Sclerosis
• Muscular dystrophy
• Neuropathic facial pain
• Osteogenesis imperfecta
• Parkinson’s Disease
• Post herpetic neuralgia
• Post-surgical back pain with a condition called chronic radiculopathy
• Post laminectomy syndrome
• Post-traumatic Stress Disorder (PTSD)
• Severe psoriasis and psoriatic arthritis
• Severe rheumatoid arthritis
• Sickle cell disease
• Spasticity
• Spasticity or Neuropathic Pain Associated with Fibromyalgia
• Terminal Illness Requiring End-Of-Life Care
• Tourette syndrome
• Ulcerative colitis
• Uncontrolled Intractable Seizure Disorder
• Vulvodynia and vulvar burning
• Wasting syndrome
• Other medical conditions may be approved by the Department of Consumer Protection

Connecticut Medical Marijuana Program

Your physician MUST be licensed to practice in the state and must also have a bona fide relationship with the patient they are certifying for medical marijuana.